Since 2021, Chinese authorities have approved 113 domestically developed innovative drugs, propelling the pharmaceutical market to a scale of 100 billion yuan (approximately 13.89 billion U.S. dollars).
This milestone was highlighted at the ongoing China Pharmaceutical Industry Development Conference in Shanghai on Saturday.
The medical device sector has also made remarkable progress. During the 14th Five-Year Plan period (2021-2025), 165 innovative devices received approval, many integrating advanced technologies such as deep learning, magnetic levitation, and magnetic resonance monitoring.
The report presented at the conference emphasizes strides in biological drug industrialization, intelligent manufacturing, and the green development of active pharmaceutical ingredients, showcasing China’s commitment to sustainable and cutting-edge pharmaceutical advancements.
The conference, which began on Saturday, will continue until November 18, gathering industry leaders to discuss the future of China’s pharmaceutical innovation and development.
Some truly interesting info , well written and loosely user pleasant.
There are some attention-grabbing closing dates in this article however I don’t know if I see all of them heart to heart. There may be some validity however I’ll take maintain opinion till I look into it further. Good article , thanks and we want more! Added to FeedBurner as effectively
Ihabe rea sso mzny polsts conerning the blogger lovers
butt this post iis really a pleasant piece of writing, keep it up.
Hello.This post was extremely remarkable, especially because I was looking for thoughts on this topic last Sunday.